
|Articles|August 30, 2016
CMIC HOLDINGS Implements goBalto Activate
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia.
Advertisement
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia. The CRO looks for the solution to improve workflows of studies being conducted in Malaysia, Singapore, Taiwan, Philippines, Thailand, Japan and South Korea.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
2
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
3
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
4
Labels That Withstand Liquid Nitrogen
5